Loading the session
Loading the session
Loading instrument
$16.32
+0.00%Delayed · Pre-marketDelayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 16:00 IST · A quote does not mean the product is available to trade on your account.
Opens 8:00 pm IST
Opens 8:00 pm IST
Opens 8:00 pm IST
In brief
Questions investors ask
Quotes run fifteen minutes behind.
1 month: +25.6% (SPY −1.6%, XLV +13.5%). 3 months: +265.1% (SPY −0.4%, XLV +15.5%). 1 year: +350.8% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: RCEL, SPY and XLV · as of 4 Nov 2026
Closed at $16.32 on 4 Nov 2026: 3.4% below the 52-week high of $16.90 (29 Oct 2026) and 406.8% above the low of $3.22 (7 Jan 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
2.8M shares were sold short at the 15 Oct 2026 settlement, 9.2% of the 30.8M shares outstanding; covering them would take 7.6 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
The 4 Nov 2026 close of $16.32 was 30.1% above its 50-day average ($12.54) and 142.4% above its 200-day average ($6.73). It has closed above the 200-day for 80 sessions, since 15 Jul 2026. The 50-day average crossed above the 200-day on 2 Jul 2026, 87 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
Price return, split-adjusted
At the 4 Nov 2026 close
Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.
August 7, 2026
+63.58%September 15, 2025
+48.25%February 24, 2023
+36.53%